☆ 4.6 Article

Histone regulator KAT2A acts as a potential biomarker related to tumor microenvironment and prognosis of diffuse large B cell lymphoma

BMC CANCER (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Molecular profiling of EBV associated diffuse large B-cell lymphoma

Fabian Frontzek et al.

Summary: EBV associated DLBCL is a rare and aggressive B-cell lymphoma subtype with adverse clinical outcome. The precise role of EBV in lymphomagenesis and specific molecular characteristics of these lymphomas remain elusive. This study provides a comprehensive molecular analysis of primary EBV+ DLBCLs, revealing recurrent mutations activating the JAK-STAT and NOTCH pathways, frequent amplifications of 9p24.1, and implications for targeting these aberrations in preclinical and clinical studies.

LEUKEMIA (2023)

添加到收藏夹

Review Oncology

How I treat diffuse large B-cell lymphoma

T. Melchardt et al.

ESMO OPEN (2023)

添加到收藏夹

Review Oncology

The evolving tumor microenvironment From cancer initiation to metastatic outgrowth

Karin E. de Visser et al.

Summary: Cancers consist of tumor cells and various non-cancerous cells in an altered extracellular matrix, forming complex ecosystems. The tumor microenvironment (TME) includes different immune cell types, cancer-associated fibroblasts, endothelial cells, pericytes, and other tissue-resident cells, all of which play critical roles in cancer pathogenesis. The composition and function of the TME can vary depending on the organ, cancer cell features, tumor stage, and patient characteristics. Understanding the interplay between tumor cell-intrinsic, cell-extrinsic, and systemic factors is crucial for developing effective anti-cancer treatments.

CANCER CELL (2023)

添加到收藏夹

Review Cell Biology

The role of tumor microenvironment on cancer stem cell fate in solid tumors

Sara Razi et al.

Summary: The role of cancer stem cells in tumor progression, including initiation, metastasis, invasion, and resistance to therapy, has been recognized as a potential target for tumor therapy. Understanding the mechanisms by which CSCs contribute to cancer progression can lead to novel therapeutic approaches against solid tumors.

CELL COMMUNICATION AND SIGNALING (2023)

添加到收藏夹

Article Hematology

Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas

Suvi-Katri Leivonen et al.

Summary: This study provides a comprehensive phenotypic characterization of post-transplant lymphoproliferative disorders (PTLD), highlighting the importance of immune cell composition in determining the clinical behavior and prognosis of PTLD.

HAEMATOLOGICA (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

KEGG for taxonomy-based analysis of pathways and genomes

Minoru Kanehisa et al.

Summary: KEGG is a manually curated database resource that integrates various biological objects classified into systems, genomic, chemical, and health information. Through the KEGG identifier and URL links, users can retrieve and browse information for different biological objects, including pathway maps, hierarchy, and genomes. KEGG has also improved KO assignment annotation and included more eukaryotic genomes for better representation of organisms in the taxonomic tree. The taxonomy mapping enables analysis of the conservation of functional and physical links among genes in different organism groups.

NUCLEIC ACIDS RESEARCH (2023)

添加到收藏夹

Article Immunology

Histone Acetylation Regulator-Mediated Acetylation Patterns Define Tumor Malignant Pathways and Tumor Microenvironment in Hepatocellular Carcinoma

Yuyan Xu et al.

Summary: This study provides the first comprehensive analysis of 36 histone acetylation regulators in hepatocellular carcinoma (HCC). Histone acetylation patterns were found to be closely associated with tumor malignant pathways and the tumor microenvironment (TME). The therapeutic value of the HAscore in targeted therapy and immunotherapy was also analyzed.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Review Oncology

Metabolic Reprogramming in Hematologic Malignancies: Advances and Clinical Perspectives

Zhuoya Yu et al.

Summary: Metabolic reprogramming, a hallmark of cancer progression, supports tumorigenesis and tumor progression by allowing cells to uptake essential nutrients and altering metabolic pathways to meet increased demands for energy and biosynthetic precursors. Activated oncogenes coordinate with altered metabolism to control cell-autonomous pathways, potentially leading to tumorigenesis. Targeting metabolic features of hematologic malignancies has shown promising therapeutic potential in both clinical and preclinical studies.

CANCER RESEARCH (2022)

添加到收藏夹

Article Oncology

Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL

Keenan T. Hartert et al.

Summary: A study identified a high-risk subset of non-GCB DLBCL patients with genomic alterations and expression signatures affecting treatment outcomes, showing unfavorable prognoses with RCHOP therapy. However, these high-risk patients had better outcomes when lenalidomide was added to RCHOP treatment.

LEUKEMIA (2021)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Revisiting the role of CD4+T cells in cancer immunotherapy-new insights into old paradigms

Rong En Tay et al.

Summary: Cancer immunotherapy has transformed cancer treatment, with immune checkpoint blockade therapy and adoptive cell therapy becoming standard care for many cancer types. Recent evidence suggests that CD4(+)T cells play a significant role in the anti-tumour immune response, highlighting their potential importance in cancer immunotherapies.

CANCER GENE THERAPY (2021)

添加到收藏夹

Article Oncology

Targeting p300/CBP Attenuates Hepatocellular Carcinoma Progression through Epigenetic Regulation of Metabolism

Ling-Yan Cai et al.

Summary: This study demonstrates p300/CBP as a critical epigenetic regulator of glycolysis-related metabolic enzymes in HCC and identifies the p300/CBP inhibitor B029-2 as a potential therapeutic strategy in this disease.

CANCER RESEARCH (2021)

添加到收藏夹

Article Oncology

HDAC5 Loss Impairs RB Repression of Pro-Oncogenic Genes and Confers CDK4/6 Inhibitor Resistance in Cancer

Yingke Zhou et al.

Summary: This study reveals the interaction of HDAC5 and RB in cancer cells, showing that HDAC5 deficiency may result in resistance to CDK4/6 inhibitors, but this effect can be overcome by the BET-CBP/p300 dual inhibitor NEO2734.

CANCER RESEARCH (2021)

添加到收藏夹

Review Medicine, Research & Experimental

The GCN5: its biological functions and therapeutic potentials

Md. Ezazul Haque et al.

Summary: GCN5 is a highly studied histone acetyltransferase that plays essential roles in epigenetic regulation and chromatin modification. It is involved in diverse biological processes such as gene regulation, cellular proliferation, metabolism, and inflammation, and its dysregulation has been linked to various disorders. Understanding the role of GCN5 in disease progression and developing novel therapeutic agents targeting GCN5 are important areas of research.

CLINICAL SCIENCE (2021)

添加到收藏夹

Article Oncology

Targeting the p300/CBP Axis in Lethal Prostate Cancer

Jonathan Welti et al.

Summary: The resistance to AR blockade in CRPC is associated with sustained AR signaling through alternative splicing of AR (AR-SV). Inhibitors of transcriptional coactivators like p300/CBP are attractive therapeutic targets for lethal prostate cancer. CCS1477, a novel small-molecule inhibitor of p300/CBP, shows promise in inhibiting cell proliferation in prostate cancer cell lines and regulating AR and C-MYC signaling.

CANCER DISCOVERY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

HDAC inhibition potentiates anti-tumor activity of macrophages and enhances anti-PD-L1-mediated tumor suppression

Xiaolei Li et al.

Summary: Pharmacological modulation of macrophage phenotype by HDAC inhibitors can reshape the tumor immune microenvironment, enhance anti-tumor immune responses, and improve the efficacy of immunotherapies in various tumors.

ONCOGENE (2021)

添加到收藏夹

Review Oncology

Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunities

Yingyue Liu et al.

Summary: B-cell lymphoma, a hematological malignancy with high clinical and biological heterogeneity, involves complex interactions between tumor cells and the tumor microenvironment. Exploring the tumor microenvironment provides new insights for cancer therapy.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

添加到收藏夹

Article Cell Biology

KAT2A-mediated AR translocation into nucleus promotes abiraterone-resistance in castration-resistant prostate cancer

Dingheng Lu et al.

Summary: Abiraterone, a novel androgen synthesis inhibitor, is approved for treating castration-resistant prostate cancer(CRPC). However, patients often develop resistance to it, and the role of Lysine acetyltransferase 2 A (KAT2A) in this resistance was investigated. Higher KAT2A expression was found in abiraterone-resistant prostate cancer cells and in patients with poor clinical outcomes. Knocking down KAT2A partially resensitized resistant cells to abiraterone, while overexpressing it promoted resistance. These findings suggest KAT2A as a potential target for CRPC treatment.

CELL DEATH & DISEASE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

The lncRNA PVT1 regulates nasopharyngeal carcinoma cell proliferation via activating the KAT2A acetyltransferase and stabilizing HIF-1α

Ying Wang et al.

CELL DEATH AND DIFFERENTIATION (2020)

添加到收藏夹

Article Oncology

Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Laurie H. Sehn et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma

Patrizia Mondello et al.

CANCER DISCOVERY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

CircMRPS35 suppresses gastric cancer progression via recruiting KAT7 to govern histone modification

Mengmeng Jie et al.

MOLECULAR CANCER (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Targeting Wnt Signaling for the Treatment of Gastric Cancer

Sarah Koushyar et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Review Oncology

Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy

Flavia Alves Verza et al.

CANCERS (2020)

添加到收藏夹

Article Oncology

Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling

Juan Yang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

添加到收藏夹

Article Oncology

Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma

Xiangxiang Zhou et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

添加到收藏夹

Article Oncology

CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality inCREBBP/EP300-mutated lymphomas

Kylee J. Veazey et al.

LEUKEMIA (2020)

添加到收藏夹

Review Oncology

Toward a New Molecular Taxonomy of Diffuse Large B-cell Lymphoma

Daisuke Ennishi et al.

CANCER DISCOVERY (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Endothelial SIRT6 Is Vital to Prevent Hypertension and Associated Cardiorenal Injury Through Targeting Nkx3.2-GATA5 Signaling

Jian Guo et al.

CIRCULATION RESEARCH (2019)

添加到收藏夹

Review Oncology

Genetic alterations and their clinical implications in DLBCL

Yi Miao et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

添加到收藏夹

Review Oncology

Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment

Xinyu Tian et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Toward understanding the origin and evolution of cellular organisms

Minoru Kanehisa

PROTEIN SCIENCE (2019)

添加到收藏夹

Article Medicine, General & Internal

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Stephen J. Schuster et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Article Hematology

Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment

Yang Liu et al.

AMERICAN JOURNAL OF HEMATOLOGY (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model

Yan Zhang et al.

CELL CHEMICAL BIOLOGY (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Genome-wide dose-dependent inhibition of histone deacetylases studies reveal their roles in enhancer remodeling and suppression of oncogenic super-enhancers

Gilson J. Sanchez et al.

NUCLEIC ACIDS RESEARCH (2018)

添加到收藏夹

Article Immunology

The Immune Landscape of Cancer

Vesteinn Thorsson et al.

IMMUNITY (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

Bjoern Chapuy et al.

NATURE MEDICINE (2018)

添加到收藏夹

Article Multidisciplinary Sciences

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Sanjeev Mariathasan et al.

NATURE (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression

Davide Pradella et al.

MOLECULAR CANCER (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours

Loren M. Lasko et al.

NATURE (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Characterization of histone acylations links chromatin modifications with metabolism

Johayra Simithy et al.

NATURE COMMUNICATIONS (2017)

添加到收藏夹

Article Cell Biology

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade

Pornpimol Charoentong et al.

CELL REPORTS (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2

Xiaofeng Liu et al.

EMBO REPORTS (2016)

添加到收藏夹

Article Cell Biology

Histone Modifications and Cancer

James E. Audia et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)

添加到收藏夹

Article Cell Biology

A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia

Konstantinos Tzelepis et al.

CELL REPORTS (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

limma powers differential expression analyses for RNA-sequencing and microarray studies

Matthew E. Ritchie et al.

NUCLEIC ACIDS RESEARCH (2015)

添加到收藏夹

Review Medicine, Research & Experimental

New and emerging HDAC inhibitors for cancer treatment

Alison C. West et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

添加到收藏夹

Article Hematology

HDAC11 plays an essential role in regulating OX40 ligand expression in Hodgkin lymphoma

Daniela Buglio et al.

BLOOD (2011)

添加到收藏夹

Article Multidisciplinary Sciences

Removing Batch Effects in Analysis of Expression Microarray Data: An Evaluation of Six Batch Adjustment Methods

Chao Chen et al.

PLOS ONE (2011)

添加到收藏夹

Article Biochemical Research Methods

ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking

Matthew D. Wilkerson et al.

BIOINFORMATICS (2010)

添加到收藏夹

Article Mathematical & Computational Biology

Adjusting batch effects in microarray expression data using empirical Bayes methods

W. Evan Johnson et al.

BIOSTATISTICS (2007)

添加到收藏夹

Article Oncology

Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis

C Sotiriou et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)

添加到收藏夹

Article Biochemistry & Molecular Biology

KEGG: Kyoto Encyclopedia of Genes and Genomes

M Kanehisa et al.

NUCLEIC ACIDS RESEARCH (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.